You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 20, 2024

CLINICAL TRIALS PROFILE FOR PEDVAXHIB

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for PEDVAXHIB

Subscribe to access the full database, or Try a Trial
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT04978818 ↗	Immunogenicity of H. Influenzae Type b PRP-OMP Vaccines in American Indian and Alaska Native Children (the HibVax Study)	Not yet recruiting	Merck Sharp & Dohme Corp.	Phase 4	2021-11-15	The main goal of this study is to compare the Haemophilus influenzae type b antibody response in American Indian / Alaska Native (AI/AN) infants to two licensed vaccines: Vaxelis and PedvaxHIB.
NCT04978818 ↗	Immunogenicity of H. Influenzae Type b PRP-OMP Vaccines in American Indian and Alaska Native Children (the HibVax Study)	Not yet recruiting	Johns Hopkins Bloomberg School of Public Health	Phase 4	2021-11-15	The main goal of this study is to compare the Haemophilus influenzae type b antibody response in American Indian / Alaska Native (AI/AN) infants to two licensed vaccines: Vaxelis and PedvaxHIB.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for PEDVAXHIB

Condition Name

Chart
Table

Condition Name for PEDVAXHIB
Intervention	Trials
Haemophilus Influenzae Type B Infection	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for PEDVAXHIB
Intervention	Trials
Influenza, Human	1
Haemophilus Infections	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for PEDVAXHIB

Trials by Country

Map
Table

Trials by Country for PEDVAXHIB
Location	Trials
United States	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for PEDVAXHIB
Location	Trials
New Mexico	1
Arizona	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for PEDVAXHIB

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for PEDVAXHIB
Clinical Trial Phase	Trials
Phase 4	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for PEDVAXHIB
Clinical Trial Phase	Trials
Not yet recruiting	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for PEDVAXHIB

Sponsor Name

Chart
Table

Sponsor Name for PEDVAXHIB
Sponsor	Trials
Merck Sharp & Dohme Corp.	1
Johns Hopkins Bloomberg School of Public Health	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for PEDVAXHIB
Sponsor	Trials
Industry	1
Other	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.